Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lisak, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lisak, R. P.
NEUROLOGY 1980;30:99-105
© 1980 American Academy of Neurology

Multiple sclerosis

Evidence for immunopathogenesis

Robert P. Lisak, M.D.

Department of Neurology, School of Medicine, University of Pennsylvania, and the Multiple Sclerosis Research Center of the University of Pennsylvania-Wistar Institute, Philadelphia, PA.

Address correspondence and reprint requests to Dr. Lisak, Department of Neurology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

I have attempted to review the evidence that one or more immunopathologic mechanisms are responsible for the clinical and pathologic findings in multiple sclerosis (MS). I believe that there is considerable evidence for an immunopathogenesis of MS, but it is not clear what type or types of reactions are involved or against which autoantigen, neoantigen, or microbial antigen the reaction is directed. In addition, there is growing evidence that there are abnormalities in immunologic control mechanisms in patients with MS, although whether these changes are a cause or a result of the disease is not clear.

Accepted for publication September 16, 1979.

This work was supported in part by U. S. Public Health Service grant No. NS 11037–07 and The National Multiple Sclerosis Society grant No. RG894-B-2.




This article has been cited by other articles:


Home page
Arch NeurolHome page
S. B. Elias
Oligodendrocyte Development and the Natural History of Multiple Sclerosis: A New Hypothesis for the Pathogenesis of the Disease
Arch Neurol, December 1, 1987; 44(12): 1294 - 1299.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.